Literature DB >> 21344427

Robotic thyroid surgery: an initial experience with North American patients.

Ronald B Kuppersmith1, F Christopher Holsinger.   

Abstract

OBJECTIVE: To review the initial experience of gasless transaxillary robot-assisted endoscopic thyroid surgery in a series of patients and describe modifications of the technique for the North American patients, selection criteria, and other issues related to this technology.
METHODS: Retrospective review of the first 31 consecutive cases at a single institution.
RESULTS: Thirty-one patients underwent robotic thyroid surgery. Twenty thyroid lobectomies and 11 total thyroidectomies were performed. Improvements in the length of time to perform components of the procedure were noted from the early group of cases to later group of cases. No major or permanent complications occurred.
CONCLUSIONS: Robotic thyroid surgery is feasible in North American patients and can be safely performed. The procedure has potential complications and a definite learning curve exists for both surgeons and operating room staff. Training methods need to be validated to ensure safe adoption. More studies need to be performed to further evaluate the relative benefits of this technique.
Copyright © 2010 The American Laryngological, Rhinological, and Otological Society, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 21344427     DOI: 10.1002/lary.21347

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  50 in total

Review 1.  Well differentiated thyroid carcinoma: current treatment.

Authors:  J Kenneth Byrd; Robert J Yawn; Christina S T Wilhoit; Nicoleta D Sora; Linda Meyers; Jyotika Fernandes; Terry Day
Journal:  Curr Treat Options Oncol       Date:  2012-03

2.  A comparative study of the surgical outcomes of robotic and conventional open modified radical neck dissection for papillary thyroid carcinoma with lateral neck node metastasis.

Authors:  Sang-Wook Kang; So Hee Lee; Jae Hyun Park; Jun Soo Jeong; Seulkee Park; Cho Rok Lee; Jong Ju Jeong; Kee-Hyun Nam; Woong Youn Chung; Cheong Soo Park
Journal:  Surg Endosc       Date:  2012-05-31       Impact factor: 4.584

3.  Long-Term Voice Outcomes After Robotic Thyroidectomy.

Authors:  Chang Myeon Song; Bo Ram Yun; Yong Bae Ji; Eui Suk Sung; Kyung Rae Kim; Kyung Tae
Journal:  World J Surg       Date:  2016-01       Impact factor: 3.352

4.  Continuous Vagal Nerve Monitoring: Too Much of a Good Thing?

Authors:  David J Terris
Journal:  World J Surg       Date:  2016-03       Impact factor: 3.352

5.  Endoscope-assisted facelift thyroid surgery: an initial experience using a new endoscopic technique.

Authors:  Jun-Ook Park; Sang-Yeon Kim; Byung-Joon Chun; Young-Hoon Joo; Kwang-Jae Cho; Young Hak Park; Min-Sik Kim; Dong-Il Sun
Journal:  Surg Endosc       Date:  2014-08-27       Impact factor: 4.584

6.  Defining anatomical landmarks for robotic facelift thyroidectomy.

Authors:  Michael C Singer; Andrew Heffernan; David J Terris
Journal:  World J Surg       Date:  2014-01       Impact factor: 3.352

7.  Functional voice and swallowing outcomes after robotic thyroidectomy by a gasless unilateral axillo-breast approach: comparison with open thyroidectomy.

Authors:  Kyung Tae; Ki Yong Kim; Bo Ram Yun; Yong Bae Ji; Chul Won Park; Dong Sun Kim; Tae Wha Kim
Journal:  Surg Endosc       Date:  2011-12-29       Impact factor: 4.584

Review 8.  Overview of robotic thyroidectomy.

Authors:  Eun Hae Estelle Chang; Hoon Yub Kim; Yoon Woo Koh; Woong Youn Chung
Journal:  Gland Surg       Date:  2017-06

9.  The current status of robotic transaxillary thyroidectomy in the United States: an experience from two centers.

Authors:  Nisar Zaidi; Despoina Daskalaki; Pablo Quadri; Alexis Okoh; Pier Cristoforo Giulianotti; Eren Berber
Journal:  Gland Surg       Date:  2017-08

10.  Robotic thyroidectomy for cancer in the US: patterns of use and short-term outcomes.

Authors:  Mohamed Abdelgadir Adam; Paul Speicher; John Pura; Michaela A Dinan; Shelby D Reed; Sanziana A Roman; Julie A Sosa
Journal:  Ann Surg Oncol       Date:  2014-06-17       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.